BetterLife Pharma Inc. Files Routine 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Apr 7, 2025 · CIK: 1464165
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
BetterLife Pharma (BETRF) filed a 6-K, standard foreign issuer report. Nothing major, just housekeeping.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on April 7, 2025, reporting for the month of April 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC, and operates in the Pharmaceutical Preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing provides an update on BetterLife Pharma Inc.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking their compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- April, 2024 (date) — Reporting Period
- April 7, 2025 (date) — Filing Date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is furnished or filed with the SEC. It is used to provide information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change date: 20150417) and Neurokine Pharmaceuticals Inc. (name change date: 20090514).
What is BetterLife Pharma Inc.'s Standard Industrial Classification (SIC) code?
BetterLife Pharma Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for BetterLife Pharma Inc.?
The fiscal year end for BetterLife Pharma Inc. is January 31 (0131).
What is the filing date and reporting period for this Form 6-K?
This Form 6-K was filed on April 7, 2025, and it reports for the month of April 2024.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 7, 2025 regarding BetterLife Pharma Inc. (BETRF).